Literature DB >> 7127229

[Immediate effects of dimenhydrinate on uterine contraction and the fetal cardiac rhythm during labor].

M Lemay, M Samaan, P St Michel, L Granger, R Pigeon.   

Abstract

The effects of intravenous administration of 100 mg of dimenhydrinate (Gravol) were studied in 20 patients during active spontaneous labour. The uterine activity and the fetal heart rate were monitored by an invasive technique. After administration of the medication the uterine activity increases significantly, and in 20% of the cases decelerations in the fetal heart rate of the hypoxic type occurred. Because of its unpredictable effects, this drug should be used with care during labour.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127229      PMCID: PMC1862164     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  7 in total

1.  THE USE OF INTRAVENOUS DIMENHYDRINATE IN LABOR.

Authors:  R S SCOTT
Journal:  New Physician       Date:  1964-09

2.  FAILURE OF DIMENHYDRINATE TO SHORTEN LABOR.

Authors:  K COOPER
Journal:  Am J Obstet Gynecol       Date:  1963-08-15       Impact factor: 8.661

3.  CLINICAL AND LABORATORY SURVEY INTO THE OXYTOCIC EFFECTS OF DIMENHYDRINATE IN LABOR.

Authors:  J A KLIEGER; J J MASSART
Journal:  Am J Obstet Gynecol       Date:  1965-05-01       Impact factor: 8.661

4.  Use of dimenhydrinate in labor.

Authors:  R S SCOTT; K H WALLACE; D N BADLEY; B H WATSON
Journal:  Am J Obstet Gynecol       Date:  1962-01-01       Impact factor: 8.661

5.  The use of intravenous dramamine to shorten the time of labor and potentiate analgesia.

Authors:  C W ROTTER; J L WHITAKER; J YARED
Journal:  Am J Obstet Gynecol       Date:  1958-05       Impact factor: 8.661

6.  The effect of dimenhydrinate on uterine contractions.

Authors:  T B Hay; C Wood
Journal:  Aust N Z J Obstet Gynaecol       Date:  1967-05       Impact factor: 2.100

7.  The acute effects of Dramamine on uterine contractability during labor.

Authors:  B Shephard; A Cruz; W Spellacy
Journal:  J Reprod Med       Date:  1976-01       Impact factor: 0.142

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.